Top Banner
APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents
89

APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Dec 25, 2015

Download

Documents

Malcolm Burns
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

APIC Fall

Seminar 2012

Stephen P. Blatt MD FACP

Medical Director Infectious Diseases TriHealth

Preventing and Controlling Infectious Agents

Page 2: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

HAIs - Overview

• 1.7 million infections/yr in US hospitals• 99,000 deaths/yr• Cost: $5-10 Billion/yr

– Some estimates as high as $30 billion/yr

• Occur in 5% of hospitalized patients• Adds at least 4 days to length of stay

Page 3: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Outline

• Procedures and Devices• Isolation Precautions• Cleaning, Disinfection, Sterilization• Risks of Construction

Page 4: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Frequency of Infection Types

• UTIs 32% • Surgical Site 22% ($10,500/case)• Pneumonia 15% ($23,000/case)• Bloodstream 14% ($25,000/case)

• Average annual hospital cost for HAIs is $572,000

Page 5: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Procedures and Devices

• Surgical Site Infections• Intravascular Devices• Urinary Catheters• Ventilator Associated Pneumonia

Page 6: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Surgical Site Infection - Background

• 1840s Semmelweis recognized importance of hand hygiene in preventing Puerperal Fever

• 1860s Germ Theory advanced by Pasteur and Koch

• 1870 Lister identified importance of antiseptics in preventing wound infection

Page 7: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

SSI - Background

• 30 million surgical procedures in US/yr• Account for 22% of all hospital acquired

infections• SSI doubles the risk for death and

increases risk of readmission by 5 times• SSI dramatically increases the cost of

medical care in the US

Page 8: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Pathogenesis of Surgical Site Infection

• Inoculum of bacteria – wound contamination– Colon most heavily colonized site

• Virulence of organism– Staph aureus (MRSA), Grp A Strep,

Clostridium perfringens most virulent

• Microenvironment of wound

-blood, foreign bodies, necrotic tissue

Host Defenses – Immune suppression

Page 9: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

SSI – Classification System

• American College of Surgeons Classification System– Class I – Clean wound: No inflammation, no

contaminated spaces encountered– Class II – Clean-contaminated: Respiratory,

urinary, GI, or genital tract involved under controlled conditions

– Class III – Contaminated wound: Open fresh wound, may have contamination from GI tract, infected urine

– Class IV – Dirty, infected wound: fecal contamination, devitalized tissue

Page 10: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.
Page 11: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

National Nosocomial Infection Survey NNIS

• Standardized scoring system for infection risk using:– Simplified scoring system from 0-3– Based on following 3 indicators:

• ACS score of contaminated or dirty (III or IV)• ASA (American Society of Anesthesia) score >= 3• Prolonged procedure time > 75th percentile for all

similar surgeries

Page 12: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

NNIS SSI Definitions

• Superficial incisional SSI– Involves only skin or subcut tissue– Purulent drainage or + culture or signs of

inflammation or Dr dx of wound infection

• Deep incisional SSI– Involves deep soft tissue – fascia or muscle

• Organ space SSI– Involves any part of the anatomy other than

the incision that was involved in the operation

Page 13: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Prevention of SSIs

• Reducing bacteria at the surgical site– Clip don’t shave– Surgical skin prep

• Povidone iodine traditionally used• Increasing data that chlorhexidine-alcohol may be

superior

– Appropriate air handling in OR– Sterilized surgical instruments– Reducing traffic in and out of OR

Page 14: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Prevention of SSIs

• Prophylactic antibiotic therapy– Antibiotic should be active against bacteria

found at the site of surgery– Must be given pre-op and highest

concentration should be in the tissue at the time of incision (ideally given 30-60 minutes prior to incision)

– Antibiotics should be discontinued within 24 hours of surgery

Page 15: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Prevention of SSIs – Host Factors

• Normothermia – hypothermia increases risk for infection

• Normal blood sugar – multiple studies reveal hyperglycemia is assoc with increased risk of infection

Page 16: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

INFECTIOUS AGENT A microbial organism with the ability to cause disease. The greater the organism's virulence (ability to grow and multiply), invasiveness (ability to enter tissue) and pathogenicity (ability to cause disease), the greater the possibility that the organism will cause an infection.

RESERVOIRA place within which microorganisms can thrive and reproduce.

PORTAL OF EXITA place of exit providing a way for a microorganism to leave the reservoir.

MODE OF TRANSMISSIONMethod of transfer by which the organism moves or is carried from one place to another.

PORTAL OF ENTRYAn opening allowing the microorganism to enter the host.

SUSCEPTIBLE HOSTA person who cannot resist a microorganism invading the body, multiplying, and resulting in infection. The host is susceptible to the disease, lacking immunity or physical resistance to overcome the invasion by the pathogenic microorganism.

Page 17: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Case 1

• 48 yo male with pneumonia in ICU with resp failure on Rocephin and Levaquin

• Day 5 of ICU stay develops T 102• Exam: still intubated

– Chest few rhonchi– Heart RRR no murmur– Abd soft/NT– R IJ TLC looks OK

Page 18: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Case 1

• CXR – clearing RLL infiltrate vs admission • UA – 5-10 WBC/HPF (from foley)• Blood cultures sent• Sputum cultures sent

Page 19: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Case 1

• Sputum culture: mixed flora• Urine culture: negative• Blood culture from central line and

peripheral site: GPC clusters

Page 20: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CLABSICentral Line-associated Blood Stream Infection

• Commonly known as “Line Sepsis”• Definition: Recognized pathogen cultured

from one or more blood cultures and not related to infection at another site (ie UTI or pneumonia) in a patient with a central line in place• Or 2 positive blood cultures of a common skin

organism (ie coag neg Staph) in a patient with signs/symptoms of infection

Page 21: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CLABSI Risk Factors

• Femoral line site• Prolonged hospitalization• Prolonged duration of catheterization• Heavy microbial colonization at insertion

site• Femoral > IJ > Subclav/PICC• Neutropenia• Prematurity• TPN

Page 22: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CLABSI Bundle

• Education in insertion, care and maintenance of central lines

• Use a catheter insertion “Checklist” for every insertion

• Hand hygeine prior to insertion• Avoid femoral site• Maximal sterile barriers (cap, gown, gloves,

drape)• Chlorhexidine based skin prep (not iodine)• Standardized dressing change protocol

Page 23: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CLABSI Additional Approachesif rates remain high

• Bathe ICU patients with Chlorhexidine on a daily basis

• Use antiseptic or antibiotic impregnated Central lines

• Use chlorhexidine-containing sponge dressing on insertion site (Biopatch)

• Use antimicrobial lock therapy

Page 24: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Approaches NOT to Use

• Do not use systemic antimicrobial prophylaxis– “just leave the patient on vanco until the line

comes out”– Do not routinely replace central lines in the

absence of infection

Page 25: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Performance Measures

• Compliance with the Insertion Bundle Checklist

• Daily assessment of need for central line• Compliance with dressing change protocol• CLABSI rate: infection/1000 catheter days

– Current national rate: 2.1/1000

Page 26: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

HCAP – Health care associated Pneumonia

• 20-50% Mortality in some studies• 15% of all hospital deaths• Mortality with Pseudomonas = 70%

Page 27: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

HCAP Risk Factors

• Intubation• ICU admission• Antibiotic therapy• Surgery – esp Abdominal, chest surgery• Chronic lung disease• Advanced age• Immunosuppression

Page 28: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

HCAP Diagnosis

• Difficult in ICU patients• New infiltrate on CXR with

– Fever, leukocytosis (>12) or confusion and– 2 of: worsening sputum, cough or dyspnea,

rales, worsening oxygenation– Positive cultures

• New Definitions begin 2013:– VAC – ventilator assoc condition– IVAC – Infection-related VAC– Possible VAP, Probable VAP

Page 29: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

VAP PreventionVentilator-associated Pneumonia

• Conduct active surveillance for VAP and measure rates

• Maintain head of bed up at 35 degrees• Perform frequent antiseptic mouth care• Promote the use of non-invasive

ventilation• Extubate as soon as possible – Daily SBT• Special approaches: ET tubes with in-line

subglottic suctioning system

Page 30: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

VAP PreventionWhat not to do

• IVIG• WBC colony stimulating factors

(Filgrastim)• Chest physiotherapy• Prophylactic inhaled or IV antibiotics

Page 31: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Case 2 46 yo WF 4 days s/p abd hysterectomy T 102, nausea, vomiting Exam: Clear lungs Mild tenderness around wound, no

erythema or drainage, mild suprapubic tenderness, Foley remains in place

UA with 1+ pro, 2+ LE, 40-60 WBCs WBC count 15,000 Bugs? Drugs?

Page 32: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CA-UTICatheter-associated UTI

• Most common HAI• 80% due to Foley catheter• 12-16% of all hospitalized patients will get

a UTI• 3-7% of patients/day with a Foley in place

Page 33: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CA-UTI Risk Factors

• Duration of catheterization• Female sex• Older age• Lack of maintenance of closed drainage

system

Page 34: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CA-UTI Prevention

• Use Foley catheter only when necessary:– Perioperative for certain surgical procedures– Urine output monitoring in critically ill patients– Acute urinary retention and obstruction– Assistance in pressure ulcer healing

• Standardized, aseptic insertion technique• Perform surveillance for infection rates

– National ICU rate: 3.4/1000 Foley days– GSH MSICU rate: 1.6/1000

Page 35: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CA-UTI Prevention

• Properly secure catheter to prevent trauma

• Maintain a sterile, closed drainage system• Keep the bag below the level of the

bladder to prevent backflow• Remove the Foley when no longer

needed!

Page 36: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CA-UTI PreventionMethods not to use

• Do not routinely use silver coated or antibiotic impregnated catheters

• Do not screen for asymptomatic bacteriuria

• Do not treat asymptomatic bacteriuria– Except before invasive urinary procedures

• Avoid catheter irrigation• Do not use systemic antibiotic prophylaxis• Do not change catheters routinely

Page 37: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Standard Precautions• If it’s wet and it’s not yours, don’t touch it!• Applicable to all patients• What Personal Protective Equipment (PPE)

to use:– What are my patient’s signs and symptoms?– What am I doing to my patient?

• Use barriers (gown, gloves, face protection)• Protect skin, clothing, mucous membranes (eye,

nose, mouth – T-zone)

Page 38: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Hand Hygiene

• Key to reducing HAIs• Improved hand hygiene compliance has

been shown to decrease HAI rates• Education of HCWs on need for and

methods for hand hygiene is required• Monitoring of hand hygiene compliance is

critical

Page 39: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Indications for Hand Hygiene

• Soap and water:– Hands visibly soiled– Before eating– After using the restroom– When contact with spore forming organisms is

suspected (C diff)

Page 40: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Indications for Hand Hygiene

• Soap/water or alcohol based hand gel:– Before and after direct patient care– Before donning sterile gloves– Before inserting invasive devices– After removing gloves– After contact with equipment in the patient’s

immediate vicinity– When moving from a contaminated body site

to a clean body site during patient care

Page 41: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Alcohol Hand Rub/Gel• When NOT to use alcohol:

1. When hands are visibly soiled2. When caring for a patient with undiagnosed

diarrhea, suspect or confirmed Clostridium difficile, Norovirus, or other enteric viruses

• Must allow it to air dry• 1 full squirt is enough• Is an adjunct to soap and water, not a

replacement

Page 42: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Methods to Monitor Hand Hygiene

• Direct observation – “secret shopper”– Allows both quantitative (% compliance) and

qualitative (soap or gel, duration of washing) evaluation

• Monitor volume of hand product used• Monitor adherence to artificial fingernail

policy

Page 43: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Contact Precautions

Reduces the risk of transmitting

microorganisms by :• direct contact (skin to skin) or• indirect contact (susceptible host to

contaminated/colonized object).Private room or cohort patients with the same organism

Gloves and gowns are worn when entering the room

Page 44: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Contact Precautions

• MRSA• VRE• C. difficile• MDROs – multi-drug resistant organisms• RSV in infants

Page 45: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Contact Precautions

Limit patient transport: minimize the risk of transmission and contamination of environmental surfaces.

Dedicate the use of non-critical

equipment.

Stethoscope, BP cuff, thermometer All equipment in the patient’s room must

be cleaned and disinfected

Page 46: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

“C Diff ”…A New Threat From an Old Enemy

• Gram positive anaerobic, bacillus

• Spore former: resistant to typical cleaning strategies requiring:

Environment – bleach Hand hygiene - soap and water

• Resides: GI tract (normal floral usually keep the bacteria to a minimum)

• Risk factors: antibiotic therapy >90% of C difficile HAIs occur after

or during antimicrobial therapy.

Page 47: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Hyper virulent strain of Clostridium difficile

» New strain produces up to 20 times more toxin

Complications:

• CDAD- C.diff associated diarrhea

• Pseudo membranous colitis

• Toxic mega colon

• Perforations of the colon

• Sepsis

• Death – Mortality rate up to 20% in the frail elderly

Page 48: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

C. difficile Interventions

• Antibiotic Stewardship• Isolate patients with diarrhea and

C.difficile immediately• Wear PPE gowns and gloves• Hand hygiene with soap and water

– Not alcohol hand gel

• Clean room surfaces and equipment with bleach

Page 49: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

12 Steps to Prevent Antimicrobial Resistance

Prevent infection Vaccinate Get invasive devices out ASAP

Diagnose and Treat Effectively Target the pathogen Access the experts

Use Antimicrobials Wisely Practice antimicrobial control Treat infection, not colonization Stop treatment when infection is cured or

unlikely Prevent Transmission

Isolate the pathogen Break the chain of infection

*from CDC slide set

Page 50: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Newest Tools in the Arsenal

• UVC devices– Kill spores

including C.diff

• Ozone and chemical gas generation devices also available

Page 51: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

MDROs – Multidrug Resistant Organisms

• MRSA (VISA, VRSA)– Methicillin-resistant Staph aureus

• ESBL-producing Gram Negatives– Extended-spectrum beta-lactamases

• KPCs– Carbepenamase producing Klebsiella

• NDM-1– New Delhi Metallobetalactamase producers

• Acinetobacter• VRE – vancomycin resistant Enterococcus

Page 52: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Multi Drug Resistant Organism (MDRO) Interventions

Administrative support: Fiscal and Human Resources

Judicious use of antibiotics Education: facility-wide, unit-

targeted Monitor the MDRO infection rates Appropriate isolation

Page 53: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Fundamental Interventions

Assess hand hygiene practices Contact Precautions Identify previously colonized patients Rapidly report MDRO lab results Provide MDRO education for health care

providers

Page 54: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Impact of MRSA: 2008-2011

49-65 % of health-care associated S. aureus infections reported to National Healthcare Safety Network (NHSN) are MRSA

National population based estimates of invasive MRSA infections 94,360 MRSA infections annually Associated 18,650 deaths each year 86% of all invasive MRSA infections are HAIs

Page 55: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Evolution of Antimicrobial Resistance

S. aureus

Penicillin

[1950s]

Penicillin-resistant

S. aureus

Methicillin

[1980s]

Methicillin-resistant

S. aureus (MRSA)

Vancomycin-ResistantS. aureus

Vancomycin-resistant

enterococcus (VRE)

Vancomycin

[1990s]

[1997]

Vancomycin

(glycopeptide) -

intermediate

resistant

S. aureus

[ 2002 ]

*from CDC slide set

Page 56: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Supplemental Measures

Active surveillance testing Surgical patients receiving implantable

devices i.e., joints, sternal wires, hardware Unit specific to identify colonized patients:

ICU patients Decolonization

Mupirocin ointment intra-nasal Chlorhexidine (CHG) wipes and CHG

surgical skin prep for surgical procedures

Page 57: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

VRE is colonized in the gastrointestinal tract.

Rectal swab cultures can be used to identify carriers or determine if a patient who was previously VRE+ is still a carrier

Contact isolation as long as the patient is a VRE carrier

Ongoing shedding of VRE is the likely reservoir of VRE in the hospital

Where do Organisms Hide?VRE

Page 58: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Multi Drug Resistant Gram-negative Rods

• Resistant to 3 or more classes of these antibiotics*:

Cephalosporins

Aminogylocosides

Carbapenems

Quinolones

Penicillins• Resistance caused by mutation or gene

sharing*As used at TriHealth, no national consensus

Page 59: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Extended Spectrum Beta Lactamase producers

• ESBL• Beta lactamase enzyme• Bacteria destroys all penicillins,

cephalosporins, and aztreonam• Generally treat with carbapenems

– Ertapenem (Invanz)– Imipenem/cilastatin (Primaxin)– Meropenam (Merrem)

Page 60: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Carbapenem-resistant Enterobacteriaceae

• CRE - colonized in the GI tract• Often are pan-resistant• Treatment options: tigecycline, colistin,

polymixin B• Not seen in US until 1992; • First identified in Klebsiella pneumoniae• New Delhi Metallo-Beta-Lactamase is

most recent

Page 61: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

CRE

• Now carbapenemase producing bacteria are found throughout the US

• Infections cause death 40-50% of the time

• Gene can spread from one bacteria to the next

• CDC-Recommendations to decrease transmission of CRE

Page 62: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Multi Drug Resistant Gram-negative Rods

• Once colonized, may remain colonized for a long time

• Screening is not practical• Use Contact Precautions to prevent

spread within the hospital

-Duration of isolation is controversial• *Hand Hygiene remains the single most

important means to reduce transmission and spread

Page 63: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Interventions

• “The single most important means to effectively reduce the transmission and horizontal spread of enterobacteriaceae and other microorganisms in all healthcare settings is compliance with the Centers for disease Control and Prevention (CDC) or the World Health Organization (WHO) handwashing guidelines”

Association for Professionals in Infection Control & Epidemiology Text, 2009.

Page 64: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Droplet Precautions

• For transmission of pathogens spread by close respiratory or mucous membrane contact

(sneezing, coughing, talking/ cough-inducing procedures)

• Larger, heavier – weighted droplets within 6 ft. of the patient

• Influenza or bacterial meningitis• Private room• Surgical mask

Page 65: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Meningitis

• 18 year old male patient admitted from urgent care center for treatment of meningitis.

One week hx of Fever to 103.2, headache, neck pain and stiffness

Denied recent infections, but did complain of a “heat rash” on and off

No sick contacts, does play football and practiced while ill

Diagnostic Findings:

Spinal tap- CSF cell count 14,200 WBCs, 400 RBCs, 90% neutrophils

CSF culture gram stain- gram negative diplococci

What is the diagnosis?

Is it Contagious?

What should we do?

Should contacts be prophylaxed?

Culture final was Neisseria meningitidisYes

Droplet Precautions, antibiotics & supportive care

Yes; family members, sports contacts, those in close contact prior to instituting Droplet Precautions.

Page 66: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Meningitis 5 types: Bacterial/Viral/Parasitic/Fungal/Non-infectious

Bacterial - caused by bacteria like:

Haemophilus influenza – DROPLET Precautions

Streptococcus pneumoniae - NO Precautions

Group B streptococcus - NO Precautions

Listeria monocytogenes - NO Precautions

Neisseria meningitidis - DROPLET Precautions

Viral (Aseptic) - caused by viruses like Enteroviruses and Herpes simplex

Parasitic - caused by parasites like Naegleria (amoeba found in lake/pond water)

Fungal - caused by fungi like Cryptococcus and Histoplasma

Non-infectious: Not contagious; causes- cancer, lupus, head injury, drugs, brain surgery

Page 67: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Airborne Precautions

• Used to prevent spread of pathogens that remain suspended in the air and travel great distances.

• Measles, chickenpox, pulmonary tuberculosis, zoster (shingles) in an immunocompromised patient, and for disseminated zoster in any patient.

Page 68: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Airborne Precautions

• Airborne isolation room with negative air pressure relative to the hall

• 6-12 air exchanges with direct exhaust of air to the outside

• Keep the door(s) shut

Page 69: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Airborne Precautions

• Fit tested N-95 Respirator• Fit check before entering• Limit transport to essential medical purposes

• Surgical mask on the patient if transport required

• Assist with respiratory hygiene by providing tissues, disposal bag, & hand gel at bedside

Page 70: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Cleaning, Disinfection, and Sterilization

• Contact between medical devices and human tissue carries the risk of transmitting infectious agents

• Numerous outbreaks have occurred and continue to occur due to inadequate cleaning and sterilization procedures

• CDC “Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008”

Page 71: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Instrument Categories for Risk Assessment

• Critical items – high risk of infection if any microbial contamination including bacterial spores– Instruments that enter sterile body cavities– Surgical instruments, cardiac and urinary

catheters, implants– Items must be purchased sterile or be

sterilized

Page 72: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Semi-critical Items

• Will contact mucous membranes and non-intact skin

-Resp therapy equipment, some endoscopes, laryngoscope blades, others

-Must be free of all vegetative organisms but may have small numbers of spores

-Requires high level disinfection

Page 73: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Non-critical Items

• Contact with intact skin but not mucous membranes

• Examples: BP cuff, bedpan, bed rails etc.

Page 74: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Methods of SterilizationDestroys all microbes including spores

• High Temperature: Steam sterilization– Used for heat tolerant Critical and Semi-

critical items

• Low Temperature: Ethylene oxide gas– Used for heat intolerant Critical and Semi-

critical items

• Liquid Immersion: Chemical sterilants– Used for heat intolerant Critical and Semi-

critical items that can be immersed in liquid

Page 75: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

High Level Disinfection

• Destroys all vegetative organisms but may leave a few viable spores

• Methods: – Heat- automated: Pasteurization– Liquid immersion: Chemical agents

• Used for Semi-critical items:– RT equipment, GI endoscopes,

bronchoscopes

Page 76: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Intermediate Level Disinfection

• Destroys vegetative bacteria, mycobacteria, fungi and viruses but not spores

• Method: EPA registered hospital disinfectants with antituberculocidal activity– Phenolics, chlorine based products

• Use: Noncritical patient care items ie BP cuff or surface with visible blood

Page 77: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Low Level Disinfection

• Destroys vegetative bacteria, fungi, viruses but not mycobacteria or spores

• EPA registered disinfectants with no tuberculocidal claim– Chlorine based, phenolics or quarternary

ammonium compounds

• Used for non-critical patient care items or surfaces with no visible blood

Page 78: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Cleaning

• Must be performed before processing for sterilization or disinfection

• Utilizes water and detergents or enzymatic cleaners in order to remove foreign material – organic or inorganic salts

Page 79: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Construction and Renovation

• Background– Construction projects have the potential to

disrupt normal air and water flow into patient care areas

– This risk for exposure to contaminated air and water has resulted in multiple outbreaks

– The Joint Commission includes evaluation of construction projects in their Environment of Care (EOC) standards

Page 80: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Basic Principles

• Infection Preventionists need to be involved in construction projects from the beginning– Involvement with facility management staff is

key to identifying necessary support needed to prevent infections in the healthcare environment

– CDC Guideline for Environmental Infection Control in Health Care Facilities

Page 81: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Basic Principles

• ICRA: Infection Control Risk Assessment– Conducted by a panel with expertise in

infection control, patient care, risk management, facility design and construction

– Provides documentation of risk assessment and mitigation strategies throughout the construction process

– The owner shall provide monitoring of the mitigation strategies

Page 82: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

ICRA Building Design Elements

• Number and location of protective environment rooms

• Location of special ventilation HVAC units• Ventilation and air handling needs in

surgical services, labs etc where particular air exchanges are recommended

• Water systems to limit Legionella growth• Finishes and surfaces that allow for

adequate cleaning and disinfection

Page 83: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

ICRA Construction Elements

• Impact of disrupting essential services to patients and staff (ie water flow)

• Determination of specific hazards and required protection levels

• Location of patients based on infection risk• Impact of potential outages or movement

of debris• Location of known hazards

Page 84: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

ICRMR Preparation

• ICRMR – Infection Control Risk Mitigation Recommendations– Patient placement and relocation– Standards for barriers to protect patients– Temporary provisions for providing safe air

and water– Protection of occupied patient areas during

demolition– Measures to educate healthcare workers and

construction workers on mitigation plans

Page 85: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Construction Related Infections

• Infections related to contaminated air sources:– Aspergillus– Rhizopus, Mucor– Penicillium– MRSA– Stachybotrys

Page 86: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Construction Related Infections

• Infections related to contaminated water sources:– Pseudomonas– Mycobacterium fortuitim– Legionella – multiple outbreaks– Acinetobacter– Aspergillus– Burkholdaria– KPC – Carbepenemase producing Klebsiella

Page 87: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Construction and Renovation Policy

• Serves as the foundation for educating the healthcare facilities leadership on the role of the ICRA and responsibilities of all members

• Ensures timely notification of the IP in order to get the ICRA done prior to initiation of the project

• Supports a systematic approach to project management

Page 88: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

APIC On-line Text

• Provides excellent detail on every phase of construction and renovation projects

• Reviews mitigation strategies for hazards that may be encountered

Page 89: APIC Fall Seminar 2012 Stephen P. Blatt MD FACP Medical Director Infectious Diseases TriHealth Preventing and Controlling Infectious Agents.

Conclusion

• Infection Prevention will become even more important in the coming years– Health systems will be “at risk” for infection– Consumers will select healthcare on the basis

of outcome data– More regulation will require well trained IPs to

implement and monitor Infection Prevention programs

• “Let’s be careful out there!”– Sgt Phil Esterhaus, Hillstreet Blues